Linoleic acid, but not oleic acid, upregulates the production of interleukin-8 by human intestinal smooth muscle cells isolated from patients with Crohn's disease

被引:28
作者
Alzoghaibi, MA
Walsh, SW
Willey, A
Fowler, AA
Graham, MF
机构
[1] Virginia Commonwealth Univ, Dept Obstet & Gynecol, Richmond, VA 23298 USA
[2] Virginia Commonwealth Univ, Dept Physiol, Richmond, VA USA
[3] Virginia Commonwealth Univ, Dept Obstet & Gynecol, Richmond, VA USA
[4] Virginia Commonwealth Univ, Dept Pediat, Richmond, VA USA
[5] Virginia Commonwealth Univ, Dept Internal Med, Richmond, VA USA
关键词
inflammatory bowel disease; Crohn's disease; IL-8; oleic acid; linoleic acid; smooth muscle cells;
D O I
10.1016/S0261-5614(03)00083-9
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background & aims: Crohn's disease is a chronic inflammatory bowel disease (IBD) of unknown etiology. In this study, we investigated the hypothesis that dietary fatty acids, linoleic acid (LA) and oleic acid (OA), could be involved in the inflammatory response through stimulation of the neutrophil chemokine, IL-8. Methods: Human intestinal smooth muscle (HISM) cells were isolated from normal patients and patients with Crohn's disease and cultured for 24 h with LA or OA in the presence or absence of oxidative stress. The concentrations of IL-8 were measured in the media and cellular oxidative stress was quantitated by measurement of thiobarbituric acid reactive substances (TBARSs). Results: Spontaneous production of IL-8 was significantly higher in HISM cells isolated from Crohn's bowel compared to control bowel. LA caused a marked, nine-fold, increase in IL-8 secretion by Crohn's cells, an effect that could be simulated in normal HISM cells by co-incubation of LA with an oxidizing solution (Ox) composed of hypoxanthine+ xanthine oxidase+FeSO4 (OxLA). These effects were inhibited by vitamins C and E. Treatment of Crohn's cells with OxLA did not further increase IL-8 over that of LA alone. The effect of LA alone was not associated with an increase in cellular oxidative stress as quantitated by TBARSs. In contrast to the results with LA, treatment with OA or OxOA did not increase IL-8 in either normal or Crohn's cells. In addition, OA protected Crohn's cells from the increase in TBARSs induced by Ox. In contrast to IL-8, spontaneous production of monocyte chemotactic protein (MCP-1) was significantly lower in Crohn's HISM cells as compared to normal cells and exposure to OxLA did not increase its production. Conclusions: LA, but not OA, increased the production of IL-8 by HISM cells. These results suggest that replacement of LA by OA in the diet of Crohn's patients and increased intake of a diet rich in antioxidants could be beneficial in decreasing inflammatory activity in Crohn's disease. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:529 / 535
页数:7
相关论文
共 48 条
[41]   INVIVO ASSESSMENT OF GRANULOCYTE MIGRATION TO DISEASED BOWEL IN CROHNS-DISEASE [J].
SAVERYMUTTU, SH ;
PETERS, AM ;
LAVENDER, JP ;
CHADWICK, VS ;
HODGSON, HJF .
GUT, 1985, 26 (04) :378-383
[42]   Epidemiologic analysis of Crohn disease in Japan: Increased dietary intake of n-6 polyunsaturated fatty acids and animal protein relates to the increased incidence of Crohn disease in Japan [J].
Shoda, R ;
Matsueda, K ;
Yamato, S ;
Umeda, N .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1996, 63 (05) :741-745
[43]   ROLE OF EICOSANOIDS AS MEDIATORS OF INFLAMMATION IN INFLAMMATORY BOWEL-DISEASE [J].
STENSON, WF .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1990, 25 :13-18
[44]   TUMOR-NECROSIS-FACTOR-ALPHA INTERLEUKIN-1-BETA, AND INTERLEUKIN-6 EXPRESSION IN INFLAMMATORY BOWEL-DISEASE [J].
STEVENS, C ;
WALZ, G ;
SINGARAM, C ;
LIPMAN, ML ;
ZANKER, B ;
MUGGIA, A ;
ANTONIOLI, D ;
PEPPERCORN, MA ;
STROM, TB .
DIGESTIVE DISEASES AND SCIENCES, 1992, 37 (06) :818-826
[45]   Oxidative stress and antioxidants in intestinal disease [J].
Thomson, A ;
Hemphill, D ;
Jeejeebhoy, KN .
DIGESTIVE DISEASES, 1998, 16 (03) :152-158
[46]  
WEISS SJ, 1989, NEW ENGL J MED, V320, P365
[47]   Effect of linoleic acid on endothelial cell inflammatory mediators [J].
Young, VM ;
Toborek, M ;
Yang, FJ ;
McClain, CJ ;
Hennig, B .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1998, 47 (05) :566-572
[48]  
ZURITA VF, 1995, DIGEST DIS, V13, P92